{"id":14230,"date":"2026-10-27T11:40:32","date_gmt":"2026-10-27T11:40:32","guid":{"rendered":"https:\/\/ngenioussolutions.com\/blog\/?p=14230"},"modified":"2026-10-27T12:49:48","modified_gmt":"2026-10-27T12:49:48","slug":"servicenow-21-cfr-part-11-compliance","status":"publish","type":"post","link":"https:\/\/ngenioussolutions.com\/blog\/servicenow-21-cfr-part-11-compliance\/","title":{"rendered":"ServiceNow 21 CFR Part 11 Compliance: E-Signatures, QMS Controls, and Validation"},"content":{"rendered":"<div style=\"border: 1px solid #e5e7eb; border-radius: 10px; overflow: hidden; margin: 28px 0; background: #ffffff; box-shadow: 0 6px 16px rgba(0,0,0,0.06);\">\n<div style=\"background: #2d55a5;\">\n<p style=\"margin: 0; font-size: 17px; font-weight: 600; color: #ffffff; padding: 12px 18px;\">Key Takeaways<\/p>\n<\/div>\n<div style=\"padding: 18px 20px;\">\n<ul style=\"margin: 0; padding-left: 20px; font-size: 14px; line-height: 1.7; color: #1f2937;\">\n<li>ServiceNow can support regulated quality workflows, but Part 11 readiness depends on configuration, validation, and documented controls.<\/li>\n<li>Electronic signatures must establish signer identity, signing time, approval meaning, and a reliable link to the record.<\/li>\n<li>Audit coverage, record-version integrity, and access governance are essential to preserving trustworthy quality records.<\/li>\n<li>Risk-based testing and controlled release management help maintain the validated state throughout the system lifecycle.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<p>A quality manager approves a corrective action in ServiceNow. The system records the approval, updates the workflow, and notifies the next person. Everything appears to work as intended.<\/p>\n<p>But would that approval hold up during an FDA inspection?<\/p>\n<p>For pharmaceutical, biotechnology, and medical device companies, that question matters as much as whether the workflow works. When organizations use electronic records and signatures for regulated activities, they must account for 21 CFR Part 11 and the underlying regulations governing those records.<\/p>\n<p><a href=\"https:\/\/ngenioussolutions.com\/technologies\/servicenow\/?utm_source=chatgpt.com\">ServiceNow<\/a> offers capabilities for workflow management, electronic approvals, access control, and audit tracking. These capabilities can support a quality management system (QMS), including deviation management, change control, and corrective and preventive action (CAPA).<\/p>\n<p>The challenge is determining which controls the platform provides, which require configuration, and which remain the regulated company\u2019s responsibility. This guide explains how ServiceNow supports Part 11 electronic signatures, where implementation gaps can arise, and how life sciences teams can approach validation.<\/p>\n<h2>What 21 CFR Part 11 Actually Requires for Electronic Signatures<\/h2>\n<p><a href=\"https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-A\/part-11\" target=\"_blank\" rel=\"noopener\">21 CFR Part 11<\/a> establishes the conditions under which the FDA considers certain electronic records and electronic signatures trustworthy, reliable, and generally equivalent to paper counterparts.<\/p>\n<p>Part 11 does not automatically apply to every electronic record in a life sciences organization. Applicability depends on underlying FDA recordkeeping or submission requirements, commonly called predicate rules, and how the organization uses the electronic record.<\/p>\n<p>The FDA\u2019s guidance on <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/part-11-electronic-records-electronic-signatures-scope-and-application\" target=\"_blank\" rel=\"noopener\">Part 11 scope and application <\/a>recommends identifying applicable records and documenting whether the organization relies on electronic or paper versions for regulated activities.<\/p>\n<ul>\n<li><strong>Signature identification and meaning. <\/strong>Signed records must show signer identity, signing date and time, and meaning, such as review or approval. (<a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.50\" target=\"_blank\" rel=\"noopener\">Source<\/a>)<\/li>\n<li><strong>Signature-to-record linking. <\/strong>Signatures must remain linked to their records so they cannot ordinarily be excised or transferred to falsify another record. (<a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.70\" target=\"_blank\" rel=\"noopener\">Source<\/a>)<\/li>\n<li><strong>Unique identity and authentication. <\/strong>Signatures must be unique to an individual; nonbiometric signatures are subject to component and control requirements. (<a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.200\" target=\"_blank\" rel=\"noopener\">Source<\/a>)<\/li>\n<li><strong>Electronic record controls. <\/strong>Closed-system controls address appropriate audit trails, access, record protection, operational checks, authority checks, and validation. (<a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.10\" target=\"_blank\" rel=\"noopener\">Source<\/a>)<\/li>\n<li><strong>Password and ID controls. <\/strong>Additional safeguards apply to identification codes and passwords used as electronic signature components.<br \/>\n(<a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.300\" target=\"_blank\" rel=\"noopener\">Source<\/a>)<\/li>\n<\/ul>\n<p>These requirements operate together. A CAPA closure should establish who signed, what record and version they signed, what the signature meant, and whether the organization can retrieve reliable evidence later.<\/p>\n<div style=\"margin: 22px 0 12px 0; padding: 25px 28px 15px; background-color: #223f8b; border-left: 4px solid #70A7FF; border-radius: 8px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; box-shadow: 0 4px 12px rgba(34, 63, 139, 0.12);\">\n<p style=\"margin: 0 0 12px 0; font-size: 10px; font-weight: bold; letter-spacing: 0.12em; text-transform: uppercase; color: #a9ccff;\">Our Services<\/p>\n<p style=\"margin: 0 0 12px 0; font-size: 20px; font-weight: bold; line-height: 1.4; color: #ffffff;\">ServiceNow Implementation Services<\/p>\n<p style=\"margin: 0 0 20px 0; font-size: 14px; line-height: 1.75; color: #d4e2ff;\">Explore how NGenious Solutions approaches ServiceNow implementation, configuration, integrations, and ongoing platform support.<\/p>\n<p><a style=\"display: inline-block; padding: 11px 16px; background-color: #ffffff; color: #223f8b; border-radius: 4px; font-size: 13px; font-weight: 600; text-decoration: none;\" href=\"https:\/\/ngenioussolutions.com\/services\/servicenow-implementation-services\/\">Explore Implementation Services \u2192<\/a><\/p>\n<\/div>\n<h2>Why Regulated Teams Build a QMS on ServiceNow, and Where Part 11 Gets Tricky<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-14231\" src=\"https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-scaled.webp\" loading=\"lazy\" alt=\"Infographic titled \u201cWhat a Part 11-ready QMS Must Prove,\u201d with the subtitle \u201cThree layers of evidence, not a single compliance toggle.\u201d It presents three components: Platform Controls (authenticated approval, audit history, and access controls), Configured QMS (record\/version linkage, workflow rules, and tested integrations), and Company Procedures (risk assessment, validation, training, and retention).\" width=\"2560\" height=\"1441\" srcset=\"https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-scaled.webp 2560w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-300x169.webp 300w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-1024x576.webp 1024w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-768x432.webp 768w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-1536x864.webp 1536w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-02-2-2048x1152.webp 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p>Life sciences organizations manage quality processes across departments, manufacturing sites, suppliers, and enterprise systems. A deviation can involve manufacturing investigation, quality review, corrective action, employee training, and formal closure. Change control may require input from engineering, manufacturing, regulatory affairs, and QA.<\/p>\n<p><a href=\"https:\/\/ngenioussolutions.com\/blog\/servicenow-itsm-features\/\">ServiceNow workflow and application development capabilities<\/a> can provide a shared environment to coordinate these processes. A configured QMS might support:<\/p>\n<ul>\n<li>Deviation intake, investigation, review, and closure.<\/li>\n<li>CAPA assignment, approval, and effectiveness checks.<\/li>\n<li><a href=\"https:\/\/ngenioussolutions.com\/blog\/servicenow-change-management\/\">Quality change control<\/a> and controlled document approvals.<\/li>\n<li>Supplier quality issues and action tracking.<\/li>\n<\/ul>\n<p>These are potential implementations, not a claim that every ServiceNow license includes a validated life sciences QMS. A workflow platform and a compliant regulated process are not the same thing.<\/p>\n<p>A CAPA application could route a record correctly and store its approval status while still lacking adequate signature authentication, record retention, audit coverage, or protection from unauthorized changes. The company must assess the configured system against its intended use and applicable requirements.<\/p>\n<p>For US medical device manufacturers, the regulatory context changed in 2026. The FDA\u2019s <a href=\"https:\/\/www.fda.gov\/medical-devices\/postmarket-requirements-devices\/quality-management-system-regulation-qmsr\" target=\"_blank\" rel=\"noopener\">Quality Management System Regulation (QMSR)<\/a> became effective February 2, 2026, incorporating ISO 13485:2016 by reference into the revised 21 CFR Part 820 framework. Medical device workflows should account for the QMSR alongside applicable Part 11 requirements.<\/p>\n<h2>How ServiceNow Handles Part 11 E-Signatures Natively<\/h2>\n<p>ServiceNow provides an Approval with e-signature plugin. Its documentation describes the plugin as <a href=\"https:\/\/www.servicenow.com\/docs\/r\/build-workflows\/approvals\/approval-with-e-signature.html\" target=\"_blank\" rel=\"noopener\">validated for 21 CFR Part 11<\/a> electronic signature requirements. It captures signer information, requires credential verification, and records approval activity. This vendor statement does not prove every customer-developed QMS workflow or configured ServiceNow instance complies with Part 11.<\/p>\n<h3>Approval with E-Signature: Re-Authentication at the Moment of Signing<\/h3>\n<p>The plugin requires approvers to authenticate before changing an approval record\u2019s state. If authentication fails, the state does not change. Credential verification can use local ServiceNow user accounts or a configured single sign-on (SSO) identity provider.<\/p>\n<p>For completed electronic approvals, ServiceNow documents capture of the printed signer name, date and time, and meaning of the action (approval or rejection). It stores these in the approval record\u2019s activity stream and audit history.<\/p>\n<p>The feature supports Change Request and Standard Change Proposal tables by default. Administrators can register other approval tables through the <a href=\"https:\/\/www.servicenow.com\/docs\/r\/build-workflows\/approvals\/t_SelectAnApprovalTable.html\" target=\"_blank\" rel=\"noopener\">e-Signature Registry<\/a>.<\/p>\n<p>For custom CAPA processes, teams should verify that signatures are enforced across all paths. A user must not be able to bypass authentication by updating approval state through a different interface or integration. Test successful and failed signing, direct edits, automated updates, delegated access, and alternate approval routes.<\/p>\n<h3>Audit Trails and Record Controls on Regulated Tables<\/h3>\n<p>Electronic signatures form only part of the evidence. A regulated QMS may also need to preserve changes to investigations, root-cause assessments, action owners, dates, and closure decisions.<\/p>\n<p>ServiceNow provides table and field auditing. Its <a href=\"https:\/\/www.servicenow.com\/docs\/r\/platform-security\/exploring-auditing.html\" target=\"_blank\" rel=\"noopener\">auditing documentation<\/a> describes recording changed fields, previous and new values, timestamps, and the user associated with a change. Audit coverage is configuration-dependent; documented exclusions can include some import-set and upgrade-related updates. Auditing settings also do not automatically apply to every related child table.<\/p>\n<p>Identify regulated records and fields, test each method of updating them, and determine how audit evidence will be retained and retrieved. Review whether privileged users can change or remove regulated data or supporting evidence outside approved procedures.<\/p>\n<p>The FDA\u2019s <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/part-11-electronic-records-electronic-signatures-scope-and-application\" target=\"_blank\" rel=\"noopener\">Part 11 guidance<\/a> describes enforcement discretion for certain audit-trail provisions. This does not remove applicable predicate-rule obligations or the need to protect record integrity.<\/p>\n<h3>Unique Identity, SSO, and Access Governance<\/h3>\n<p>SSO simplifies access but does not independently establish signature compliance. A regulated company needs to know who owns each signature, how identity was verified, who may approve particular records, and what happens when someone changes roles or leaves.<\/p>\n<p>Test identity-provider integration in the deployed environment, including active SSO sessions, user provisioning and deprovisioning, privileged access, and authentication behavior. Signature evidence must remain attributable to a specific individual, not a shared or reassigned account.<\/p>\n<h2>Where Native Capability Needs Extending: Configure, Customize, or Buy<\/h2>\n<p>The practical question is whether the complete QMS design satisfies intended-use requirements. Separate gaps into three choices.<\/p>\n<ul>\n<li><strong>Configure existing capabilities. <\/strong>Use native approvals, auditing, access controls, and workflow checks when documented functionality fits the process.<\/li>\n<li><strong>Extend or customize. <\/strong>Custom quality applications may require signature meanings, approved-record version controls, specific presentation formats, or inspection-ready exports. Changes require controlled development and testing.<\/li>\n<li><strong>Evaluate a specialized solution. <\/strong>Substantial regulated workflow requirements may justify a dedicated QMS application or qualified integration. Vendor assurance evidence supports, but does not replace, the organization\u2019s assessment.<\/li>\n<\/ul>\n<p>Consider document approval. ServiceNow\u2019s <a href=\"https:\/\/www.servicenow.com\/docs\/r\/servicenow-platform\/document-management-services\/t_EnableElectronicSignature.html\" target=\"_blank\" rel=\"noopener\">document management e-signature guidance<\/a> says the digital signature itself is not tracked or stored in the document record. Teams must evaluate the relationship between document revision, approval record, signature evidence, and any exported document.<\/p>\n<p>A gap assessment should ask: What must the process prove? Which native controls support it? What is still unsupported? How will the final design be verified and maintained?<\/p>\n<h2>Example: A CAPA Approval That Preserves Signature Evidence<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-14232\" src=\"https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-scaled.webp\" loading=\"lazy\" alt=\"Process infographic titled \u201cIllustrative CAPA Electronic Approval Workflow,\u201d showing four sequential steps: Controlled Record (CAPA findings and defined revision), QA Authentication (authorized signer re-authenticates), Signature Evidence (name, time, and meaning linked to approval), and Inspection Check (retrieve record, version, and change history). A note states that this is a conceptual process and that actual controls, version links, alternate update paths, and retrieval must be verified in the deployed instance.\" width=\"2560\" height=\"1441\" srcset=\"https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-scaled.webp 2560w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-300x169.webp 300w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-1024x577.webp 1024w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-768x432.webp 768w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-1536x865.webp 1536w, https:\/\/ngenioussolutions.com\/blog\/wp-content\/uploads\/2026\/10\/ServiceNow-21-CFR-03-2-2048x1153.webp 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p>Consider an illustrative medical device CAPA workflow built on ServiceNow. A quality engineer documents the investigation and proposed corrective action. Before the CAPA can close, the process routes the defined record version to an authorized QA approver. The organization has configured an e-signature control for that approval step.<\/p>\n<p>The approver reviews the investigation, completes the required re-authentication, and signs with a clearly defined approval meaning. The system associates the approval evidence with the relevant record and records the action date and time. A reviewer must be able to retrieve the signed record, identify the specific approved version, and inspect the related change history.<\/p>\n<p>The team then tests attempted bypasses: an unauthorized user, an approval-state update through an integration, a later edit to the signed record, and an export for inspection. If one of these routes breaks the required evidence chain, the process needs additional controls or a different design before regulated use.<\/p>\n<p>This is a conceptual example, not a description of an out-of-the-box ServiceNow QMS or an actual customer deployment. The company must determine which controls and records are required by its applicable regulations and intended use.<\/p>\n<h2>Validating Your ServiceNow QMS: CSV, CSA, and GAMP 5<\/h2>\n<p>Computerized system validation (CSV) is an established term in regulated operations. Computer software assurance (CSA) emphasizes a risk-based way to establish confidence in software used for particular regulated activities. The objective is demonstrating suitability for intended use.<\/p>\n<p>In February 2026, the FDA issued revised final Computer Software Assurance guidance for medical device production and quality management system software. The guidance recommends a risk-based approach to establishing confidence in software and selecting assurance activities. It is not a blanket replacement for validation obligations in pharmaceutical or biotechnology systems. Read the <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/computer-software-assurance-production-and-quality-management-system-software\" target=\"_blank\" rel=\"noopener\">FDA guidance<\/a>.<\/p>\n<p>Organizations may also use <a href=\"https:\/\/ispe.org\/topics\/gamp\" target=\"_blank\" rel=\"noopener\">ISPE GAMP 5, Second Edition<\/a> principles for computerized-system life cycle and risk management.<\/p>\n<ol>\n<li>Define intended use: processes, records, signatures, integrations, predicate rules, and required outcomes.<\/li>\n<li>Assess risk: effects on patient safety, product quality, data integrity, and applicable compliance.<\/li>\n<li>Map requirements: distinguish native, configured, customized, and third-party controls.<\/li>\n<li>Evaluate supplier evidence: review current release documentation and its limits.<\/li>\n<li>Test critical functions: include signature authentication, authorization, record integrity, and CAPA closure.<\/li>\n<li>Retain objective evidence: maintain assessments, results, deviations, approvals, and configuration records.<\/li>\n<\/ol>\n<p>An informational dashboard may warrant a different level of testing than an electronic signature authorizing a regulated quality decision. Evidence should reflect that difference.<\/p>\n<h3>Keeping the Validated State Through ServiceNow Releases<\/h3>\n<p>Validation does not end at go-live. Releases, configuration changes, scripts, integrations, and access-policy updates can affect regulated workflows. An approval-interface change could alter signature authentication; an integration change could affect audit coverage.<\/p>\n<p>Maintain an inventory of relevant configurations and customizations, assess planned changes, run proportional regression tests, and retain impact-assessment evidence, including justified decisions not to run additional tests.<\/p>\n<h2>The Procedural Controls Software Cannot Provide<\/h2>\n<p>A configured QMS cannot replace organizational policies. Under 21 CFR 11.10(i) and (j), organizations must address personnel qualifications and written policies that hold individuals accountable for actions taken under their electronic signatures.<\/p>\n<ul>\n<li>Identity verification before assigning electronic signatures.<\/li>\n<li>Employee training and signature accountability.<\/li>\n<li>Role assignment, periodic access reviews, and account termination.<\/li>\n<li>Regulated record reviews, incident investigation, and data integrity.<\/li>\n<li>Backup, retention, recovery, and inspection access.<\/li>\n<li>Change control and periodic assessment of system performance.<\/li>\n<\/ul>\n<p>An important administrative requirement appears under <a href=\"https:\/\/www.law.cornell.edu\/cfr\/text\/21\/11.100\" target=\"_blank\" rel=\"noopener\">21 CFR 11.100(c)<\/a>: organizations using electronic signatures must certify to the FDA that they intend those signatures to be legally binding equivalents of handwritten signatures. The certification must bear a traditional handwritten signature and may be submitted electronically or on paper. Consult the <a href=\"https:\/\/www.fda.gov\/industry\/getting-started-esg-nextgen\/letters-non-repudiation-agreement\" target=\"_blank\" rel=\"noopener\">FDA\u2019s non-repudiation information<\/a> for related submission information. This is a company obligation, not a plugin feature.<\/p>\n<h2>Five Common Part 11 Mistakes on ServiceNow<\/h2>\n<ol>\n<li><strong> Treating a vendor statement as system-wide compliance.<\/strong> ServiceNow\u2019s plugin-level validation statement does not certify a customer\u2019s workflows, integrations, or procedural controls.<\/li>\n<li><strong> Assuming every approval is a regulated electronic signature.<\/strong> An approval status alone does not necessarily include the required authentication and signature evidence.<\/li>\n<li><strong> Enabling auditing without testing its coverage.<\/strong> Verify tables, excluded fields, integrations, deletions, export behavior, and retention.<\/li>\n<li><strong> Losing the link between signature and record version.<\/strong> Reviewers must establish which record or revision was approved and prevent unauthorized modification.<\/li>\n<li><strong> Treating validation as a one-time project.<\/strong> Manage the validated state with documented change assessment and risk-based regression testing.<\/li>\n<\/ol>\n<h2>Assess Your ServiceNow QMS Readiness<\/h2>\n<p>Before deploying a regulated quality workflow, assess where the intended design supports electronic signature authentication, record integrity, approval authorization, audit coverage, and risk-based assurance. NGenious Solutions can discuss your technical requirements and implementation options; formal regulatory determinations should involve your qualified QA and regulatory teams.<\/p>\n<p>Request a ServiceNow QMS readiness discussion to identify potential gaps in approval flows, signature controls, integrations, and assurance planning.<\/p>\n<p style=\"margin-top: 25px !important; margin-bottom: 30px !important;\"><a style=\"padding: 11px 13px; border-radius: 3px; background-color: #e7b124; color: #101010; font-size: 15px; font-weight: 500;\" href=\"https:\/\/bookings.cloud.microsoft\/book\/NGeniousSolutions1@ngenioussolutions.com\/?ismsaljsauthenabled\">Assess Your ServiceNow QMS Readiness<\/a><\/p>\n<h2>Conclusion<\/h2>\n<p>ServiceNow can provide a foundation for regulated quality workflows with authenticated approvals, audit tracking, and access-controlled processes. But Part 11 readiness depends on more than enabling electronic signatures.<\/p>\n<p>Life sciences companies need to establish which records fall within regulatory scope, configure appropriate controls, validate intended use, and maintain reliable evidence throughout the system life cycle.<\/p>\n<p>For QA leaders, the priority is confidence in the quality record. For IT teams, it is a controlled, maintainable implementation. A documented gap assessment gives both groups a practical starting point.<br \/>\nExplore how NGenious Solutions approaches ServiceNow implementation, configuration, integrations, and ongoing platform support.<\/p>\n<div style=\"margin: 25px 0 10px 0; padding: 25px 30px 12px; background: linear-gradient(115deg, #EEF4FC 0%, #E3EDFC 100%); border: 1px solid #C7D9F2; border-left: 5px solid #2D55A5; border-radius: 10px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; box-shadow: 0 5px 18px rgba(45, 85, 165, 0.08);\">\n<p style=\"margin: 0 0 12px 0; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; font-size: 11px; font-weight: bold; letter-spacing: 0.12em; text-transform: uppercase; color: #2d55a5;\"><span style=\"background-color: #d5e4fc; padding: 6px 10px; border-radius: 4px;\">Free Consultation<\/span><\/p>\n<p style=\"margin: 0 0 12px 0; font-size: 23px; font-weight: bold; color: #172b4d; line-height: 1.4;\">Planning regulated quality workflows <span style=\"color: #2d55a5;\">on ServiceNow?<\/span><\/p>\n<p style=\"margin: 0 0 24px 0; font-size: 15px; color: #45546a; line-height: 1.75;\">NGenious Solutions can help you review your workflow architecture, electronic signature requirements, audit coverage, and integration considerations. Schedule a consultation to discuss your implementation priorities and potential technical gaps.<\/p>\n<p><a style=\"display: inline-block; font-size: 14px; font-weight: 600; color: #ffffff; background-color: #2d55a5; padding: 13px 23px; border-radius: 6px; text-decoration: none; box-shadow: 0 3px 8px rgba(45, 85, 165, 0.2);\" href=\"https:\/\/outlook.office.com\/book\/NGeniousSolutions1@ngenioussolutions.com\/?ismsaljsauthenabled\" target=\"_blank\" rel=\"noopener\">Book a ServiceNow consultation \u00a0\u2192<\/a><\/p>\n<\/div>\n<h2>Frequently Asked Questions<\/h2>\n<h5>1. Is ServiceNow 21 CFR Part 11 compliant?<\/h5>\n<p>ServiceNow documents its Approval with e-signature plugin as validated for Part 11 electronic signature requirements. Compliance for a specific regulated use depends on the configured system, records, controls, procedures, and validation evidence.<\/p>\n<h5>2. Can ServiceNow be used for GxP processes?<\/h5>\n<p>Yes. It can support configured workflows such as deviation management, CAPA, quality change control, and document approval. Suitability depends on intended use, applicable requirements, controls, and assurance evidence.<\/p>\n<h5>3. Does 21 CFR Part 11 require validation?<\/h5>\n<p>Section 11.10(a) contains a validation provision for closed systems. The FDA\u2019s 2003 Part 11 guidance describes enforcement discretion for that specific provision, but this discretion does not waive applicable predicate-rule obligations. Teams should base their assurance and testing approach on intended use, documented risk, and the requirements applicable to their records and processes.<\/p>\n<h5>4. Is computer software assurance replacing CSV?<\/h5>\n<p>Not universally. FDA\u2019s February 2026 CSA guidance describes a risk-based approach for medical device production and quality management system software, not a blanket change to every regulated software system.<\/p>\n<h5>5. Do I need to send a letter to the FDA for electronic signatures?<\/h5>\n<p>Section 11.100(c) requires certification that electronic signatures are intended to be legally binding equivalents of handwritten signatures. The certification requires a traditional handwritten signature and can be submitted electronically or on paper.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways ServiceNow can support regulated quality workflows, but Part 11 readiness depends on configuration, validation, and documented controls. Electronic signatures must establish signer identity,&#8230;<\/p>\n","protected":false},"author":7,"featured_media":14233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[212],"tags":[390],"class_list":["post-14230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-servicenow-blogs","tag-servicenow"],"menu_order":0,"_links":{"self":[{"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/posts\/14230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/comments?post=14230"}],"version-history":[{"count":7,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/posts\/14230\/revisions"}],"predecessor-version":[{"id":14241,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/posts\/14230\/revisions\/14241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/media\/14233"}],"wp:attachment":[{"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/media?parent=14230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/categories?post=14230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ngenioussolutions.com\/blog\/wp-json\/wp\/v2\/tags?post=14230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}